Agape ATP Corporation
AATP
$8.00 -55.56%
Exchange: OTC | Sector: Consumer Defensive | Industry: Household Personal Products
Q4 2024
Published: Dec 31, 2024

Earnings Highlights

  • Revenue of $0.36M down 8% year-over-year
  • EPS of $-0.20 decreased by 1% from previous year
  • Gross margin of 49.5%
  • Net income of -808.44K
  • "" -
AATP
Company AATP

Executive Summary

Executive Summary: Agape ATP Corporation (AATP) reported Q4 2024 revenue of USD 359,776 thousand with a gross profit of USD 177,982 thousand and a gross margin of 49.47%. The quarter delivered a meaningful sequential revenue increase (+8.6% QoQ) but remained deeply unprofitable on an operating basis, with operating income of USD -848,109 thousand and EBITDA of USD -779,622 thousand, resulting in a net income of USD -808,439 thousand and an EPS of -0.20. The year-on-year revenue trend declined by 8.0%, while quarterly QoQ momentum suggests modest top-line improvement into year-end; however, profitability deteriorated meaningfully on a year-over-year basis due to sustained high cost structure. Management commentary is not included in the provided transcript, limiting direct quotes; nonetheless, the quarterly SG&A burden (USD 1,026,091 thousand) clearly dominates the cost base alongside elevated cost of revenue (USD 181,794 thousand). Cash flow from operations was negative at USD -645,335 thousand, and free cash flow was USD -646,775 thousand, signaling ongoing cash burn at the operating level despite a cash balance of USD 2,040,243 thousand. On the balance sheet, total assets stood at USD 3.24 million with total liabilities of USD 1.31 million and shareholders’ equity of USD 1.93 million. The company holds cash and equivalents well in excess of short- and long-term debt (net debt of USD -1,677,463 thousand), underscoring a strong liquidity cushion that provides optionality for strategic actions. Valuation remains challenging: price-to-sales at ~13.1x and a negative price-to-earnings multiple reflect the current profitability weakness even as the business preserves liquidity. The near-term investment implication hinges on whether Agape ATP can meaningfully scale revenue while stabilizing or reducing fixed costs to approach break-even. In the absence of an earnings call transcript, management’s qualitative path remains inferred from the reported line items and industry context.

Key Performance Indicators

Revenue
Decreasing
359.78K
QoQ: 8.60% | YoY: -8.00%
Gross Profit
Decreasing
177.98K
49.47% margin
QoQ: -3.37% | YoY: -25.24%
Operating Income
Increasing
-848.11K
QoQ: -54.73% | YoY: 16.53%
Net Income
Increasing
-808.44K
QoQ: -58.63% | YoY: 17.03%
EPS
Decreasing
-0.20
QoQ: -53.85% | YoY: -1 462.50%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q3 2025 0.37 -0.01 +11.9% View
Q2 2025 0.47 -0.01 +48.7% View
Q1 2025 0.29 -0.18 -9.3% View
Q4 2024 0.36 -0.20 -8.0% View
Q3 2024 0.33 -0.13 -6.8% View